Elevance Health Inc

ELV: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|s$LOCK|@r$P%LOCK|gtjf!h

Elevance Health: Near-Term Headwinds Do Not Erase Long-Term Prospects

When medical utilization started surging in its important Medicaid end market, Elevance Health sold off from roughly $550 per share in mid-2024 to around $310 in early trading on March 2. On a forward basis, the shares are trading at about 12 times deflated 2026 earnings.

Sponsor Center